Split-intron retroviral vectors: Enhanced expression with improved safety

Journal of Virology

Volumn 74, Issue 5, 2000, Pages 2365-2371

  Ismail, Said I ^a   Kingsman, Susan M ^a,b   Kingsman, Alan J ^a,b   Uden, Mark ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b OXFORD BIOMEDICA UK LTD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ARTICLE; CELL LINE; GENE THERAPY; INTRON; PRIORITY JOURNAL; RETROVIRUS; REVERSE TRANSCRIPTION; VIRUS EXPRESSION; VIRUS REPLICATION;

BASE SEQUENCE; CELL LINE; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; INTRONS; MOLECULAR SEQUENCE DATA; RETROVIRIDAE; TRANSCRIPTION, GENETIC; TRANSDUCTION, GENETIC;

EID: 0033962412     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.5.2365-2371.2000     Document Type: Article

References (37)

1. Bothwell, A. L., M. Paskind, M. Reth, T. Imanishi-Kari, K. Rajewsky, and D. Baltimore. 1981. Heavy chain variable region contribution to the NPb family of antibodies: somatic mutation evident in a gamma 2a variable region. Cell 24:625-637.
2. Brinster, R. L., J. M. Allen, R. R. Behringer, R. E. Gelinas, and R. D. Palmiter. 1988. Introns increase transcriptional efficiency in transgenic mice. Proc. Natl. Acad. Sci. USA 85:835-840.
3. Braddock, M., M. Muckenthaler, M. R. White, A. M. Thorburn, J. Sommerville, A. J. Kingsman, and S. M. Kingsman. 1994. Intron-less RNA injected into the nucleus of Xenopus oocytes accesses a regulated translation control pathway. Nucleic Acids Res. 22:5255-5264.
4. Brondyk, B. 1994. PCI and pSI mammalian expression vectors. Promega Notes 49:7.
5. Buchman, A. R., and P. Berg. 1988. Comparison of intron-dependent and intron-independent gene expression. Mol. Cell. Biol. 8:4395-4405.
6. Byun, J., S. H. Kim, J. M. Kim, S. S. Yu, P. D. Robbins, J. Yim, and S. Kim. 1996. Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy. Gene Ther. 3:780-788.
7. Choi, T., M. Huang, C. Gorman, and R. A. Jaenisch. 1991. A generic intron increases gene expression in transgenic mice. Mol. Cell. Biol. 11:3070-3074.
8. Cosset, F. L., Y. Takeuchi, J. L. Battini, R. A. Weiss, and M. K. Collins. 1995. High-titer packaging cells producing recombinant retroviruses resistant to human serum. J. Virol. 69:7430-7436.
9. Dzierzak, E. A., T. Papayannopoulou, and R. C. Mulligan. 1988. Lineage-specific expression of a human beta-globin gene in murine bone marrow transplant recipients reconstituted with retrovirus-transduced stem cells. Nature 331:35-41.
10. Evans, M. J., and R. C. Scarpulla. 1989. Introns in the 3′-untranslated region can inhibit chimeric CAT and beta-galactosidase gene expression. Gene 84:135-142.
11. Hamer, D. H., and P. Leder. 1979. Splicing and the formation of stable RNA. Cell 18:1299-1302.
12. Huang, M. T., and C. M. Gorman. 1990. Intervening sequences increase efficiency of RNA 3′ processing and accumulation of cytoplasmic RNA. Nucleic Acids Res. 18:937-947.
13. Julias, J. G., D. Hash, and V. K. Pathak. 1995. E-vectors: development of novel self-inactivating and self-activating retroviral vectors for safer gene therapy. J. Virol. 69:6839-6846.
14. Karlsson, S., T. Papayannopoulou, S. G. Schweiger, G. Stamatoyannopoulos, and A. W. Nienhuis. 1987. Retroviral-mediated transfer of genomic globin genes leads to regulated production of RNA and protein. Proc. Natl. Acad. Sci. USA 84:2411-2415.
15. Krall, W. J., D. C. Skelton, X. J. Yu, I. Riviere, P. Lehn, R. C. Mulligan, and D. B. Kohn. 1996. Increased levels of spliced RNA account for augmented expression from the MFG retroviral vector in hematopoietic cells. Gene Ther. 3:37-48.
16. Lachmi, B., and L. Kaariainen. 1977. Control of protein synthesis in Semliki Forest virus-infected cells. J. Virol. 22:142-149.
17. Li, K. J., and H. Garoff. 1996. Production of infectious recombinant Moloney murine leukemia virus particles in BHK cells using Semliki Forest virus-derived RNA expression vector. Proc. Natl. Acad. Sci. USA 93:11658-11663.
18. Li, K. J., and H. Garoff. 1998. Packaging of intron-containing genes into retrovirus vectors by alphavirus vectors. Proc. Natl. Acad. Sci. USA 95:3650-3654.
19. Matsumoto, K., K. M. Wassarman, and A. P. Wolffe. 1998. Nuclear history of a pre-mRNA determines the translational activity of cytoplasmic mRNA. EMBO J. 17:2107-2121.
20. Mayeda, A., and Y. Ohshima. 1988. Short donor site sequences inserted within the intron of beta-globin pre-mRNA serve for splicing in vitro. Mol. Cell. Biol. 8:4484-4491.
21. Miller, A. D., M. A. Bender, E. A. Harris, M. Kaleko, and R. E. Gelinas. 1988. Design of retrovirus vectors for transfer and expression of the human beta-globin gene. J. Virol. 62:4337-4345.
22. Miller, A. D., and G. J. Rosman. 1989. Improved retroviral vectors for gene transfer and expression. BioTechniques 7:980-982, 984-986, 989-990.
23. Morgenstern, J. P., and H. Land. 1990. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18:3587-3596.
24. Neel, H., D. Weil, C. Giansante, and F. Dautry. 1993. In vivo cooperation between introns during pre-mRNA processing. Genes Dev. 7:2194-2205.
25. Niwa, M., S. D. Rose, and S. M. Berget. 1990. In vitro polyadenylation is stimulated by the presence of an upstream intron. Genes Dev. 9:1552-1559.
26. Palmiter, R. D., E. P. Sandgren, M. R. Avarbock, D. D. Allen, and B. L. Brinster. 1991. Heterologous introns can enhance expression of transgenes in mice. Proc. Natl. Acad. Sci. USA 88:478-482.
27. Pandey, N. B., N. Chodchoy, T. J. Liu, and W. F. Marzluff. 1990. Introns in histone genes alter the distribution of 3′ ends. Nucleic Acids Res. 18:3161-3170.
28. Pinol-Roma, S., and G. Dreyfuss. 1992. Shuttling of pre-mRNA binding proteins between nucleus and cytoplasm. Nature 355:730-732.
29. Rabson, A. B., and B. J. Graves. 1997. Synthesis and processing of viral RNA, p. 205-261. In J. M. Coffin, S. Hughes, and H. Varmus (ed.), Retroviruses. Cold Spring Harbor Laboratory Press, Plainview, N.Y.
30. Riviere, I., K. Brose, and R. C. Mulligan. 1995. Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Proc. Natl. Acad. Sci. USA 92:6733-6737.
31. Sagliocco, F. A., M. R. Vega Laso, D. Zhu, M. F. Tuite, J. E. McCarthy, and A. J. Brown. 1993. The influence of 5′-secondary structures upon ribosome binding to mRNA during translation in yeast. J. Biol. Chem 268:26522-26530.
32. Soneoka, Y., P. M. Cannon, E. E. Ramsdale, J. C. Griffiths, G. Romano, S. M. Kingsman, and A. J. Kingsman. 1995. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 23:628-633.
33. Sterner, D. A., T. Carlo, and S. M. Berget. 1996. Architectural limits on split genes. Proc. Natl. Acad. Sci. USA 93:15081-15085.
34. Telesnitsky, A., and S. P. Goff. 1997. Reverse transcriptase and the generation of retroviral DNA, p. 121-160. In J. M. Coffin, S. Hughes, and H. Varmus (ed.), Retroviruses. Cold Spring Harbor Laboratory Press, Plainview, N.Y.
35. Wassarman, K. M., and J. A. Steitz. 1993. Association with terminal exons in pre-mRNAs: a new role for the U1 snRNP? Genes Dev. 7:647-659.
36. Wengler, G. 1975. Protein synthesis in BHK-21 cells infected with Semliki Forest virus. J. Virol. 17:10-19.
37. Yu, S. F., T. von Ruden, P. W. Kantoff, C. Garber, M. Seiberg, U. Ruther, W. F. Anderson, E. F. Wagner, and E. Gilbon. 1986. Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc. Natl. Acad. Sci. USA 83:3194-3198.